BioSpace News Archive

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that it will release fourth quarter and year-end 2020 financial results Tuesday, March 30, 2021.

The objective of filing the Shelf Prospectus is to provide the Company with the financial flexibility to take advantage of financing opportunities and favourable market conditions, if and when desired, once the filing is made final.

Solid Biosciences Inc., (Nasdaq: SLDB) a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the closing of its previously announced underwritten public offering of 25,000,000 shares of its common stock at a public offering price of $5.75 per share, including 3,260,869 shares sold pursuant to the full exercise of the underwriters’ option to purchase additional shares

Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, reported that on March 22, 2021, the Company granted non-qualified stock options to purchase an aggregate of 300,000 shares of the Company’s common stock to its newly hired President, Dr. Rand Sutherland.

Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, will hold a conference call on Friday, March 26, 2021, at 12:00 p.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2020. The Company will report its financial results in a press release prior to the conference call. Date: Friday, March 26, 2021 Time: 12:00 p.m.

Labcorp continues to make progress executing our strategy and capitalizing on the power of our diagnostic and drug development businesses.

Nortech Systems Incorporated (Nasdaq: NSYS) (the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, aerospace & defense and industrial markets, reported net sales of $104.1 million for the year ended December 31, 2020, a decline of 10.5% compared to $116.3 for fiscal 2019

The Academic Orthopedic Consortium Women’s Leadership Forum powered by Breg proudly honors Orthopaedic Surgeon Leader Kristy Weber, MD who served as the 1st female President of the American Academy of Orthopedic Surgeons in 2019.

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today reported financial results and operational updates for the quarter and year ended December 31, 2020.

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced it will report financial results for the fourth quarter and full year 2020 after the close of U.S. markets on Tuesday, March 30, 2021.